Among target genes of miR-99a, peptidase inhibitor 15 (PI15) has been reported to act as a novel blood diagnostic marker for cholangiocarcinoma, and the plasma PI15 level in HCC patients was clearly higher than normal [24]. This evidence concerns the gene PI15 and cholangiocarcinoma.